Plasma proteomic profiles of SCLC patients treated with ICIs combined with anti-angiogenic therapy as second- or further-line treatment

Name: Plasma proteomic profiles of SCLC patients treated with ICIs combined with anti-angiogenic therapy as second- or further-line treatment
Creator: Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Published: 2025-02-25T12:46:27+08:00